These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 16447748

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Novel vaccine therapy for Alzheimer's disease--recent progress and our approach].
    Okura Y, Matsumoto Y.
    Brain Nerve; 2008 Aug; 60(8):931-40. PubMed ID: 18717197
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
    Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, Holmes C, Nicoll JA.
    Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunotherapy as treatment for Alzheimer's disease.
    Hawkes CA, McLaurin J.
    Expert Rev Neurother; 2007 Nov; 7(11):1535-48. PubMed ID: 17997702
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of anti-Abeta vaccination as a promising therapy for Alzheimer's disease.
    Okura Y, Matsumoto Y.
    Drug News Perspect; 2007 Nov; 20(6):379-86. PubMed ID: 17925892
    [Abstract] [Full Text] [Related]

  • 13. Lessons from the AN 1792 Alzheimer vaccine: lest we forget.
    Robinson SR, Bishop GM, Lee HG, Münch G.
    Neurobiol Aging; 2004 Nov; 25(5):609-15. PubMed ID: 15172738
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Abeta vaccination and treatment of Alzheimer's disease].
    Takeda K, Hara H.
    No To Shinkei; 2005 Oct; 57(10):867-76. PubMed ID: 16277231
    [No Abstract] [Full Text] [Related]

  • 17. Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.
    Matsuda J, Kaminaka K, Nozaki C.
    Biochem Biophys Res Commun; 2009 Apr 24; 382(1):149-52. PubMed ID: 19265678
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
    Geylis V, Steinitz M.
    Autoimmun Rev; 2006 Jan 24; 5(1):33-9. PubMed ID: 16338209
    [Abstract] [Full Text] [Related]

  • 20. Evidence supporting a role for anti-Abeta antibodies in the treatment of Alzheimer's disease.
    Morgan D, Gitter BD.
    Neurobiol Aging; 2004 Jan 24; 25(5):605-8. PubMed ID: 15172737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.